← Back to home

FDA Clears Daily Pill Pimjetmi for Rare Joint Tumor TGCT

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

U.S. regulators have approved pimicotinib, sold as Pimjetmi by EMD Serono, to treat symptomatic tenosynovial giant cell tumor, or…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

4 confirmed facts, 2 open questions and 2 sources behind this story.

About this story

We haven’t published a correction to this story.

How NewsPlain works
← Back to home